Marksans Pharma Limited has informed the Exchange regarding a press release dated July 02, 2024, titled "Marksans Pharma Limited s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products ".
Marksans Pharma Limited has informed the Exchange regarding a press release dated July 02, 2024, titled "Marksans Pharma Limited s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products ".